Author(s):
Anilkumar J. Shinde, Sachin S. Khandekar, Manish S. Bhatia, Firoj A. Tamboli, Ravindra J. Jarag, Harinath N. More
Email(s):
ajshinde07@rediffmail.com
DOI:
10.52711/0974-360X.2023.00935 
Address:
Anilkumar J. Shinde1*, Sachin S. Khandekar1, Manish S. Bhatia2, Firoj A. Tamboli3, Ravindra J. Jarag4, Harinath N. More1
1Dept. of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Kolhapur (M.S), India.
2Dept. of Pharma Chemistry, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Kolhapur (M.S), India.
3Dept. of Pharmacognosy, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Kolhapur (M.S), India.
4Dept. of Pharmacology, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Kolhapur (M.S), India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 12,
Year - 2023
ABSTRACT:
The present work was proposed to chemically modified Pectin with its hydrophilicity reduced and potential for being an universal excipient. The Bulk densities of NTGT granules were found to be 0.3473 which indicate good packing capacity. Carr’s index of NTGT granules were found to be 5.88 which indicate excellent flow properties. Hausner ratio of NTGT granules were found to be 1.0621. Angle of repose of NTGT granules were excellent flow properties. The formulations MP1P2 after optimization to limit the release in the first 3 hrs could also be equally effective. Comparative evaluation of the designed formulations, the release of nateglinide from tablets coated with eudragit RL100 was progressively prolonged, as concentration of eudragit in the coating solution was increased about 63.91% at 12hr of NTGEUD3 batch. The formulated batches gives a clear indication that once daily formulations of nateglinide as oral hypoglycemics drug can be designed using this approach and subsequent release at a consistently uniform rate for sustained action has been achieved.
Cite this article:
Anilkumar J. Shinde, Sachin S. Khandekar, Manish S. Bhatia, Firoj A. Tamboli, Ravindra J. Jarag, Harinath N. More. Comparative Evaluation of Formulations Designed using Chemically Modified Pectin and Eudragit for Sustained Release of Nateglinide. Research Journal of Pharmacy and Technology. 2023; 16(12):5775-1. doi: 10.52711/0974-360X.2023.00935
Cite(Electronic):
Anilkumar J. Shinde, Sachin S. Khandekar, Manish S. Bhatia, Firoj A. Tamboli, Ravindra J. Jarag, Harinath N. More. Comparative Evaluation of Formulations Designed using Chemically Modified Pectin and Eudragit for Sustained Release of Nateglinide. Research Journal of Pharmacy and Technology. 2023; 16(12):5775-1. doi: 10.52711/0974-360X.2023.00935 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-12-36
REFERENCES:
1. Atyabi F., Majzoob S., Imam M., and Salehi M. In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water- soluble macromolecules to colon. Carbohydrate Polymers. 2005; 61:39-51.
2. Bankar, G., Peck, G., Jan, S., and Pirikitikulr, P. Evaluation of hydroxypropyl cellulose and hydroxypropyl methylcellulose as aqueous based film coatings. Drug. Dev. Ind. Pharm. 1981; 7: 693-716.
3. Bhatia M.S., Deshmukh R., Choudhary P., Bhatia, N. M. Chemical Modification of Pectins, Characterization and Evaluation for Drug Delivery, Scintia Pharmaceutica. 2008; 7.
4. Cobby, J., Mayersohn, M., and Walker, G. C. Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental. J. Pharm. Sci. 1974; 63: 732-737.
5. Einhorn-Stoll U., Kunzek H., and Dongowski G. Thermal analysis of chemically and mechanically modified pectins. Food. Hydrocolloids. 2007;21:1101-1112.
6. Heng P. W., Chen L. W. Easterbrook M. G., and Li X. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J. Control. Release. 2001; 76(1-2): 39-49.
7. Kravtchenko T. P. Voragen, A. G. J., and Pilnik W. Analytical comparison of three industrial pectin preparations. Carbohydr Polym. 1992;18:17-25.
8. Lerk C. F., Bolhuis G.K., Smallenbrock A. J. Interaction of tablet disintegrants and magnesium stearate during mixing II: effect on dissolution rate. Pharma. Acta. Helv. 1982;57: 282-286.
9. Lisa B. P., Polymers in Controlled Drug Delivery. Biomaterials. 1997;1-13.
10. Lowenthal W. Mechanism of tablet disintegrants. Pharm. Acta. Helv. 1973; 48, 589-609.
11. Muniz E. C., and Reis A. V. Reaction of pectin and glycidyl methacrylate and ulterior formation of free films by reticulation. Int. J. Pharm. 2008;12:12-18.
12. Patel N. R., and Hopponen R. E. Mechanism of action of starch as a disintegrating agent in aspirin tablets. J. Pharm. Sci. 1966;55:1065-1068.
13. Peppas, N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 1985; 60:110-111.
14. Rowe, R. C. The molecular weight and molecular weight distribution of hydroxypropyl methylcellulose used in the film coating of tablets. J. Pharm. Pharmacol. 1980; 32:116-119.
15. Sinha, V. R., and Kumria, R. Polysaccharides in colon-specific drug delivery, Int J Pharm. 2001;224:19-38.
16. Sriamornsak P., and Thirawong N. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur. J. Pharm. Biopharm. 2007;67: 211-219.
17. Sungthongjeen S., Sriamonsak P., Pitaksuteepong T., Somsiri S. Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets. AAPS. Pharm. Sci. Tech. 2004;5(1):9-14.
18. Duggi Adilakshmi, Abdul Saleem Mohammad, Nuha Rasheed, Kathula Umadevi, Chandana Pasupuleti. Simultaneous Formulation, Estimation and Evaluation of Allopurinol Sustained Release Tablets using various suitable Excipients. Asian J. Pharm. Ana. 2016; 6(3): 155-166. doi: 10.5958/2231-5675.2016.00025.9
19. Dilip M. Kumbhar, Vijay D. Havaldar, Kailas K. Mali, Remeth J. Dias, Vishwajeet S. Ghorpade, Rahul B. Londhe. Formulation and Evaluation of Sustained Release Tablets of Venlafaxine Hydrochloride for the treatment of Depressive disorders. Asian J. Pharm. Res. 2017; 7(1): 8-14. doi: 10.5958/2231-5691.2017.00002.8
20. Manmohan S. Jangdey, Anshita Gupta and Abhishek K. Sah. Development and Evaluation of Mucoadhesive Sustained Release Tablet using Tamarindus indica Gum. Asian J. Res. Pharm. Sci. 2014; 4(2): 77-82.
21. V Jhansipriya Marabathuni, P. Dinesh, R. Ravikumar, P. Yamini, P. Sai Kiran, Sd. P.Hussain, Ch. M.M. Prasada Rao. Chitosan Based Sustained Release Mucoadhesive Buccal Patches Containing Amlodipine Besylate (AMB). Asian J. Res. Pharm. Sci. 2017; 7(2): 97-104. doi: 10.5958/2231-5659.2017.00015.7
22. Y. Krishna Reddy, Gazala Nousheen. Formulation and Evaluation of Oxcarbazepine Sustained release Matrix tablets. Asian J. Res. Pharm. Sci. 2020; 10(3): 161-164. doi: 10.5958/2231-5659.2020.00031.4
23. Basavaraj, Someswara Rao B, S.V Kulkarni, Pramod Patil, Chetan Surpur. Design and Characterization of Sustained Release Aceclofenac Matrix Tablets Containing Tamarind Seed Polysaccharide. Asian J. Pharm. Tech. 2011; 1(1):17-21.
24. Pooja Shetty, Ravi Kumar, Yamunappa, Prathibha Suvarna, Narayana Swamy VB. Design and Evaluation of Sustained Release Matrix Tablets of Etodolac. Asian J. Pharm. Tech. 2016; 6(1): 01-14. doi: 10.5958/2231-5713.2016.00001.5
25. Ganesan V, Jayachandran DL. Design and Evaluation of Matrix Tablets of Ambroxol Hydrochloride using Guargum. Research J. Pharm. and Tech. 2008; 1(4): 507-512.
26. SH Lakade, MR Bhalekar. Formulation and Evaluation of Sustained Release Matrix Tablet of Anti-Anginal Drug, Influence of Combination of Hydrophobic and Hydrophlic Matrix Former. Research J. Pharm. and Tech. 2008; 1(4): 410-413.
27. Manmohan S. Jangdey, Anshita Gupta, Abhishek K. Sah. Formulation and Evaluation of Sustained Release Topical Gel of Flurbiprofen Using Natural Polymers. Research J. Topical and Cosmetic Sci. 2014; 5(1): 7-11.